BlackRock’s Inhibrx INBX Stock Holding History
Bought
Maintained
Sold
Other funds holding INBX
PA
S
SSA
WP
BlackRock's INBX Position: Q2 2026 in Review
BlackRock increased its Inhibrx (INBX) stake by 3.4% in Q2 2026, buying an estimated $2.71M and bringing the position to 825,972 shares worth $78.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2368.
BlackRock first reported a position in INBX in Q2 2024 and has held it in 9 quarters since. 163 funds tracked by Wall St. Rank hold INBX as of Q2 2026.
- BlackRock held 825,972 shares of Inhibrx worth $78.3M as of Q2 2026.
- BlackRock bought 27,074 Inhibrx shares in Q2 2026, an estimated $2.71M.
- Inhibrx made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #2368 holding.
- BlackRock first reported a position in Inhibrx in Q2 2024 and has held it in 9 quarters since.
- 163 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.
Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.